U.S. Colorectal Cancer Market

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service provides the market overview, market trends, patient and revenue forecasts for colorectal cancer in the U.S. from 2006-2016. The patient population and revenue forecasts are discussed in terms of staging and line of therapy. This includes in-depth analysis of the market segmented by line of therapy providing competitive information and pipeline analysis. This research service also captures results from the Frost & Sullivan "Voice of the Customer" analysis of drug delivery in oncology. This research service serves as an update to F205-52 on the U.S. colorectal cancer market published in 2005-06.

Table of Contents

U.S. Colorectal Cancer Market, Executive SummaryU.S. Colorectal Cancer MarketIntroductionU.S. Colorectal Cancer Market, Market IntroductionResearch Scope and MethodologyScope and SegmentationResearch MethodologyMarket OverviewColorectal CancerMarket Engineering MeasurementsStaging DefinitionsTreatment by StageCost of Therapy EstimationsProduct AnalysisU.S. Colorectal Cancer Market, Market AnalysisCompetitive AnalysisCompetitive StructureIndustry ChallengesPipeline AnalysisMarket Share AnalysisPatient ForecastsIncidence and Staging ForecastsPatient Forecasts by Line of TherapyRevenue ForecastsTotal Market ForecastsAdjuvant Therapy ForecastsFirst-line Therapy ForecastsSecond and Third-line Therapy ForecastsCombined Forecasts by Line of TherapyVoice of the Customer AnalysisOpportunities in OncologyTechnology PerspectiveFrequency of Use of Drug Delivery MethodsWillingness to Use Drug Delivery MethodsPreferred Drug Delivery ScheduleImportance of Factors in Method SelectionU.S. Colorectal Cancer Market, AppendixDecision Support DatabasesColorectal Cancer MorbidityColorectal Cancer IncidenceSmoker PrevalencePharmaceutical R&D ExpenditureGovernment R&D Expenditure in BiotechnologyTotal Cancer Incidence




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.